Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status
Year: 2020
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Gonadal steroid hormones have been suggested as the underlying mechanism responsible for the sexual dimorphism observed in metabolic diseases. Animal studies have also evidenced a causal role of the gut microbiome and metabolic health. However, the role of sexual dimorphism in the gut microbiota and the potential role of the microbiome in influencing sex steroid hormones and shaping sexually dimorphic susceptibility to disease have been largely overlooked. Although there is some evidence of sex-specific differences in the gut microbiota diversity, composition, and functionality, the results are inconsistent. Importantly, most of these studies have not taken into account the gonadal steroid status. Therefore, we investigated the gut microbiome composition and functionality in relation to sex, menopausal status, and circulating sex steroids. RESULTS: No significant differences were found in alpha diversity indices among pre- and post-menopausal women and men, but beta diversity differed among groups. The gut microbiota from post-menopausal women was more similar to men than to pre-menopausal women. Metagenome functional analyses revealed no significant differences between post-menopausal women and men. Gonadal steroids were specifically associated with these differences. Hence, the gut microbiota of pre-menopausal women was more enriched in genes from the steroid biosynthesis and degradation pathways, with the former having the strongest fold change among all associated pathways. Microbial steroid pathways also had significant associations with the plasma levels of testosterone and progesterone. In addition, a specific microbiome signature was able to predict the circulating testosterone levels at baseline and after 1-year follow-up. In addition, this microbiome signature could be transmitted from humans to antibiotic-induced microbiome-depleted male mice, being able to predict donor's testosterone levels 4 weeks later, implying that the microbiota profile of the recipient mouse was influenced by the donor's gender. Finally, obesity eliminated most of the differences observed among non-obese pre-menopausal women, post-menopausal women, and men in the gut microbiota composition (Bray-Curtis and weighted unifrac beta diversity), functionality, and the gonadal steroid status. CONCLUSIONS: The present findings evidence clear differences in the gut microbial composition and functionality between men and women, which is eliminated by both menopausal and obesity status. We also reveal a tight link between the gut microbiota composition and the circulating levels of gonadal steroids, particularly testosterone. Video Abstract.
Source: Microbiome
Institutions: Universitat de Girona, Instituto de Salud Carlos III, Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition, Institut d'Investigació Biomèdica de Girona, Hospital Universitari de Girona Doctor Josep Trueta, Instituto Maimónides de Investigación Biomédica de Córdoba, Centro de Investigación Biomédica en Red, Hospital Universitario Reina Sofía, Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable, University of Córdoba, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Consejo Superior de Investigaciones Científicas, Universitat de València, Institute for Integrative Systems Biology, Universitat Pompeu Fabra, Vilnius University, Hospital Del Mar, Municipal Institute for Medical Research, Hospital del Mar Research Institute
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,990
Funders: European Commission, Ministerio de Economía y Competitividad, Generalitat Valenciana, Horizon 2020 Framework Programme, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III, European Regional Development Fund, Agencia Estatal de Investigación, FP7 Ideas: European Research Council
Awards: G1178615512, G1691526961, G1747313373, G216061351, G2190014636, G2340393674, Estudio de la biosíntesis intestinal de LBP y células de Paneth en relación con la sensibilidad a insulina y obesidad, G2765649280, G3458054101, G3529070748, Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity, G4937468798, G5220002527, G5985610733, G6049260834, Neuropathic pain: biomarkers and druggable targets within the endogenous analgesia system, G6406793217, Estudio del contenido de hierro en tejido adiposo, músculo y cerebro de sujetos obesos. Interacción con la composición de la microbiota y efectos de la pérdida de peso
OpenAlex ID: W3087310015
